We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Black Tea Consumption Reduces Blood Pressure

By HospiMedica International staff writers
Posted on 07 Feb 2012
A new study shows that regular consumption of flavonoid rich black tea significantly reduces blood pressure (BP).

Researchers at the University of Western Australia (UWA; Perth, Australia) conducted a randomized, placebo-controlled study involving 95 men and women who were regular tea drinkers. More...
Participants had a mean body mass index (BMI) of 25 kg/m2 and a mean daytime ambulatory systolic blood pressure of 121 mm Hg at baseline. During a four-week run-in period, all of the participants consumed a low-flavonoid diet along with three cups of regular leaf tea per day. During the six-month intervention period, the participants were randomized to three cups per day of either 1,493-mg powdered black tea solids that contained 429 mg of polyphenols and 96 mg of caffeine, or a placebo drink matched in flavor and caffeine content.

The results showed that drinking three cups each day for six months lowered both diastolic and systolic BP. For systolic readings, BP was lower by 2.7 mm Hg at three months and 2.0 mm Hg lower at six months in the participants who were drinking tea. For diastolic BP, the differences were 2.3 and 2.1 mm, respectively. According to the researchers, even these small changes could have a large impact on health at a population level, resulting in a possible 10% reduction in the prevalence of hypertension and a 7%-10% decrease in the risk of cardiovascular disease (CVD). The study was published on January 23, 2011, in Archives of Internal Medicine.

“Endothelial dysfunction may be an early marker for changes in blood pressure, and there is evidence that tea consumption improves endothelial function,” concluded lead author Jonathan Hodgson, PhD, and colleagues. “Tea flavonoids affect nitric oxide status and reduce levels of endothelin; this could contribute to reduced vascular tone and lower blood pressure. Another possible mechanism involves the effects of tea flavonoids on body weight and visceral fatness.”

Tea is an aromatic beverage prepared by adding cured leaves of the Camellia sinensis plant to hot water; the term also refers to the plant itself. After water, tea is the most widely consumed beverage in the world worldwide and is usually the major source of flavonoids, often providing more than half of total intake. There are at least six different types of tea: white, yellow, green, oolong, black, and postfermented teas. A tea's type is determined by the processing which it undergoes; black tea is wilted, sometimes crushed, and is fully oxidized. The halting of oxidization is done by heating, and is carried out simultaneously with the drying.

Related Links:
University of Western Australia



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Surgical System
Stealth AXiS
New
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.